Key Takeaways: Over the past six months, states have been proactive in their consideration or reconsideration of next steps pertaining to coverage of Glucagon-like Peptide (GLP)-1s weight loss medication
Consult with a healthcare professional or a certified fitness trainer to create a personalized exercise plan that suits your needs and abilities
Among them, anti-obesity drugs have high compliance rates and cause noticeable short-term effects in reducing obese levels
Most major medical organizations support sustained use when clinically appropriate
If the drugs are directly both improving weight reduction and cancer reduction, then we need to double down. Ganta wonders the same thing about the drugs apparent positive effects on several conditions, from dementia to sleep apnea: Is it that obesity is causing or contributing to the problem [and that weight loss is causing the improvement], or is the medication directly having an impact through a different mechanism? She hopes there will be more research to parse this out in the years to come
Clinical trials demonstrate reductions in alanine aminotransferase (ALT) and aspartate aminotransferase (AST)key markers of liver healthoften correlating with decreased hepatic fat accumulation
